Cargando…

Application of Direct Renin Inhibition to Chronic Kidney Disease

PURPOSE: Chronic kidney disease has serious implications with a high risk for progressive loss of renal function, increased cardiovascular events as well as a substantial financial burden. The renin-angiotensin-aldosterone system (RAAS) is activated in chronic kidney disease, especially in diabetes...

Descripción completa

Detalles Bibliográficos
Autor principal:	Mende, Christian W.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer US 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2887501/ https://www.ncbi.nlm.nih.gov/pubmed/20490905 http://dx.doi.org/10.1007/s10557-010-6232-1

Ejemplares similares

Direct Renin Inhibitor: Aliskiren in Chronic Kidney Disease
por: Morishita, Yoshiyuki, et al.
Publicado: (2012)

Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007)

Effect of add-on direct renin inhibitor aliskiren in patients with non-diabetes related chronic kidney disease
por: Li, Szu-yuan, et al.
Publicado: (2012)

Dual inhibition of renin-angiotensin-aldosterone system and endothelin-1 in treatment of chronic kidney disease
por: Komers, Radko, et al.
Publicado: (2016)

Chronic Kidney Disease and SGLT2 Inhibitors: A Review of the Evolving Treatment Landscape
por: Mende, Christian W.
Publicado: (2021)

Retarding the progression of chronic kidney disease with renin angiotensin system blockade
por: Limesh, M., et al.
Publicado: (2012)

Do inhibitors of the renin–angiotensin system prevent chronic kidney disease?
por: Rayner, Brian
Publicado: (2010)

The role of renin angiotensin system inhibition in kidney repair
por: van der Meer, Irene M, et al.
Publicado: (2010)

Management of Chronic Kidney Disease: The Relationship Between Serum Uric Acid and Development of Nephropathy
por: Mende, Christian
Publicado: (2015)

Direct renin inhibition – a promising strategy for renal protection?
por: Lizakowski, Sławomir, et al.
Publicado: (2013)

Characterization of the intrarenal renin‐angiotensin system in cats with naturally occurring chronic kidney disease
por: Lourenço, Bianca N., et al.
Publicado: (2022)

(Pro)renin Receptor in Kidney Development and Disease
por: Song, Renfang, et al.
Publicado: (2011)

Human kidney pericytes produce renin
por: Stefanska, Ania, et al.
Publicado: (2016)

Inhibition of the renin-angiotensin system during fetal kidney development
por: Park, Eujin
Publicado: (2020)

Clinical Implication of the Renin-angiotensin-aldosterone Blockers in Chronic Kidney Disease Undergoing Hemodialysis
por: Morishita, Yoshiyuki, et al.
Publicado: (2014)

Effects of Direct Renin Inhibition on Myocardial Fibrosis and Cardiac Fibroblast Function
por: Zhi, Hui, et al.
Publicado: (2013)

Treatment effects of renin-angiotensin aldosterone system blockade on kidney failure and mortality in chronic kidney disease patients
por: Vejakama, Phisitt, et al.
Publicado: (2017)

Renin gene rs1464816 polymorphism contributes to chronic kidney disease progression in ADPKD
por: Ramanathan, Gnanasambandan, et al.
Publicado: (2016)

Role of renin–angiotensin–aldosterone system inhibitors in heart failure and chronic kidney disease
por: Singhania, Namrata, et al.
Publicado: (2020)

Renin–angiotensin–aldosterone pathway modulators in chronic kidney disease: A comparative review
por: Alshahrani, Saeed
Publicado: (2023)

STUDIES CONCERNING THE SITE OF RENIN FORMATION IN THE KIDNEY : I. THE ABSENCE OF RENIN IN THE AGLOMERULAR KIDNEY OF THE MIDSHIPMAN FISH
por: Friedman, Meyer, et al.
Publicado: (1942)

New class of agents for treatment of hypertension: focus on direct renin inhibition
por: Fogari, Roberto, et al.
Publicado: (2010)

The RenTg Mice: A Powerful Tool to Study Renin-Dependent Chronic Kidney Disease
por: Huby, Anne-Cecile, et al.
Publicado: (2012)

Efficacy of Direct Renin Inhibitors in Slowing Down the Progression of Diabetic Kidney Disease: A Meta-Analysis
por: Akbariromani, Hanieh, et al.
Publicado: (2022)

Acute acid load in chronic kidney disease increases plasma potassium, plasma aldosterone and urinary renin
por: Bovée, Dominique M, et al.
Publicado: (2020)

Effect of calcifediol supplementation on renin‐angiotensin‐aldosterone system mediators in dogs with chronic kidney disease
por: Miller, Matthew, et al.
Publicado: (2022)

The renin-angiotensin system and aging in the kidney
por: Yoon, Hye Eun, et al.
Publicado: (2014)

Injury, failure or success? Renin–angiotensin system inhibition in acute kidney injury
por: Ellam, Tim, et al.
Publicado: (2011)

Pathogenesis of Chronic Kidney Disease Is Closely Bound up with Alzheimer’s Disease, Especially via the Renin-Angiotensin System
por: Ma, Ke, et al.
Publicado: (2023)

Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway
por: Wang, Yan-Ni, et al.
Publicado: (2022)

Prevalence of aldosterone breakthrough in dogs receiving renin‐angiotensin system inhibitors for proteinuric chronic kidney disease
por: Ames, Marisa K., et al.
Publicado: (2022)

Renin-angiotensin-aldosterone system blockers in Bulgarian COVID-19 patients with or without chronic kidney disease
por: Filev, Rumen, et al.
Publicado: (2022)

Renin-Angiotensin System - Considerations for Hypertension and Kidney
por: Yim, Hyung Eun, et al.
Publicado: (2008)

Adherence to long-term use of renin-angiotensin II-aldosterone system inhibitors in children with chronic kidney disease
por: Hsu, Chien-Ning, et al.
Publicado: (2019)

Changes of FGF23 and the Renin-Angiotensin-System in Male Mouse Models of Chronic Kidney Disease and Cardiac Hypertrophy
por: Okamoto, Kohei, et al.
Publicado: (2021)

Lab monitoring and acute care utilization during initiation of renin angiotensin aldosterone inhibitors or diuretics in chronic kidney disease
por: Garlo, Katherine G., et al.
Publicado: (2019)

Responses of the renin–angiotensin–aldosterone system in pregnant chronic kidney disease patients with and without superimposed pre-eclampsia
por: Kurlak, Lesia O, et al.
Publicado: (2019)

Renin–angiotensin system blockers during the COVID-19 pandemic: an update for patients with hypertension and chronic kidney disease
por: Theodorakopoulou, Marieta P, et al.
Publicado: (2021)

Effect of Discontinuation of Renin Angiotensin-System Inhibitors in Patients With Advanced Chronic Kidney Disease: A Meta-Analysis
por: Naveed, Husnain, et al.
Publicado: (2023)

Activation of the intrarenal renin-angiotensin-system in murine polycystic kidney disease
por: Saigusa, Takamitsu, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_q8526apirjgi2nqsh6rk8uijon